|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/513 | (2006.01) |
| A61P 9/04 | (2006.01) | ||
| A61P 9/10 | (2006.01) |
| (11) | Number of the document | 3661514 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18759209.2 |
| Date of filing the European patent application | 2018-08-03 | |
| (97) | Date of publication of the European application | 2020-06-10 |
| (45) | Date of publication and mention of the grant of the patent | 2025-09-17 |
| (46) | Date of publication of the claims translation | 2025-11-10 |
| (86) | Number | PCT/US2018/045180 |
| Date | 2018-08-03 |
| (87) | Number | WO 2019/028360 |
| Date | 2019-02-07 |
| (30) | Number | Date | Country code |
| 201762541591 P | 2017-08-04 | US | |
| 201762584537 P | 2017-11-10 | US | |
| 201862639922 P | 2018-03-07 | US | |
| 201862671585 P | 2018-05-15 | US |
| (72) |
SEMIGRAN, Marc J. , US
LEE, June H. , US
LAMBING, Joseph , US
GREEN, Eric , US
EVANCHIK, Marc , US
CARLSON, Timothy , US
ZHANG, David , US
|
| (73) |
MyoKardia, Inc. ,
1000 Sierra Point Parkway, Brisbane, CA 94005,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Mavakamtenas, skirtas naudoti gydant hipertrofinę kardiomiopatiją |
| MAVACAMTEN FOR USE IN THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY |